View : 633 Download: 0
Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies
- Title
- Menopausal hormone therapy and the risk of breast cancer by histological type and race: a meta-analysis of randomized controlled trials and cohort studies
- Authors
- Kim S.; Ko Y.; Lee H.J.; Lim J.-E.
- Ewha Authors
- 이화정
- SCOPUS Author ID
- 이화정
- Issue Date
- 2018
- Journal Title
- Breast Cancer Research and Treatment
- ISSN
- 0167-6806
- Citation
- Breast Cancer Research and Treatment vol. 170, no. 3, pp. 667 - 675
- Keywords
- Breast cancer; Hormone replacement therapy; Menopausal hormone therapy; Meta-analysis
- Publisher
- Springer New York LLC
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Purpose: This meta-analysis investigated the association between the risk of breast cancer and hormone replacement therapy (HRT). Various stratified analyses were performed according to race (Asian/Westerner), HRT type [all hormone therapies, estrogen-only therapy (ET), or combined estrogen–progestin therapy (EPT)], histological breast cancer type (ductal/lobular/mixed ductal–lobular), and estrogen receptor status (ER-positive/ER-negative). Methods: A literature search was performed using Pubmed, Embase, and KoreaMed. Twenty-five epidemiological studies including 23 cohort studies and two randomized controlled trials were included in this meta-analysis. Results: Using a random-effects model, HRT use was found to be positively associated with the risk of breast cancer with a pooled hazard ratio (HR) of 1.33 [95% confidence interval (CI) 1.24, 1.44]. Compared with ET, EPT was more strongly associated with breast cancer risk. EPT was associated with both ductal and lobular breast cancer risks [for ductal breast cancer, HR = 1.51 (95% CI 1.28, 1.78); for lobular breast cancer, HR = 1.38 (95% CI 1.20, 1.60)]. According to ER status, all HRTs were associated with the risk of ER-positive breast cancer, but not with that of ER-negative breast cancer. Conclusions: Asian HRT users had a higher risk of breast cancer than western HRT users. Both ET and EPT were significantly associated with the risk of all breast cancer histological types and ER-positive breast cancer. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
- DOI
- 10.1007/s10549-018-4782-2
- Appears in Collections:
- 약학대학 > 약학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML